Easing the Agitation Burden: Evidence-Based Approaches to Addressing Agitation Associated With Dementia due to Alzheimer’s Disease

This educational program aims to improve the knowledge, competence, and performance of healthcare professionals in optimizing treatment for patients with agitation associated with dementia (AAD) and Alzheimer’s disease. It targets psychiatrists, neurologists, primary care physicians, physician associates, pharmacists, social workers, and psychologists who manage AAD patients in specialty and primary care practice settings.

Share

Program Content

Activities

AAD MEDX slides
Easing the Agitation Burden: Evidence-Based Approaches to Addressing Agitation Associated With Dementia due to Alzheimer’s Disease
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: September 10, 2024

Expires: September 09, 2025

AAD Psych Update APP slides
Restoring Serenity: Evidence-Based Strategies for Managing Agitation in Alzheimer’s Disease
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: September 18, 2024

Expires: September 17, 2025

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC 

Supporters

Supported by an educational grant from Otsuka America Pharmaceutical, Inc. and Lundbeck.

Lundbeck

Otsuka America Pharmaceutical, Inc.

Partners

Alzheimer's Foundation of America

ProCE Banner